MEYLIN VEGA: Open Payments
NPI 1992042493 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 52 payments from 19 companies in 2025. Trend: 2023 $692 · 2024 $995 · 2025 $1,302
Food & beverage: $1,193Education: $109
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $270 |
| Arcutis Biotherapeutics, Inc. | 4 | $195 |
| ABBVIE INC. | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Organon LLC | 8 | $67 |
| Incyte Corporation | 3 | $64 |
| Almirall LLC | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Amgen Inc. | 1 | $52 |
Products named: Zoryve, ILUMYA, SPEVIGO, SKYRIZI, OPZELURA, Rhapsido, OTEZLA, EBGLYSS.
Industry payments across FL — which companies pay providers there.
